VEGFA and central nervous system cancer: The lack of effect of the IDH 1/2 mutation on the concentrations of VEGF-A and VEGF-R2 suggests that both proteins are independent biomarkers, and moreover, the conducted research shows that only the method for determining VEGF-A in glioma is 100% sensitive and specific.